Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

Clinical trials

Schedule appointment (352) 265-8240
Dr. Crispen talking to two people
  • Intravesical BCG vs GEMDOCE in NMIBC (BRIDGE)

    The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will result in a non-inferior event-free survival (EFS) compared to standard treatment with…

    Investigator
    Padraic O'Malley
    Ages
    18 Years - N/A
    Sexes
    All